Disclosed herein are compounds of Formula I
as disclosed herein, methods of modulating the activity of an estrogen receptor and methods of treating a disorder associated with estrogen receptors.
CONDENSED COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS
申请人:Acadia Pharmaceuticals Inc.
公开号:EP2200994B1
公开(公告)日:2014-01-22
ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES
申请人:The Regents of the University of California
公开号:US20170304216A1
公开(公告)日:2017-10-26
The present invention relates to treatment of neurological diseases such as multiple sclerosis (MS) and Alzheimer's disease, using an estrogen receptor beta (ERβ) ligand.